{"id":"NCT01514461","sponsor":"Novartis Pharmaceuticals","briefTitle":"A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome","officialTitle":"A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-07","primaryCompletion":"2014-05","completion":"2014-05","firstPosted":"2012-01-23","resultsPosted":"2015-06-03","lastUpdate":"2015-06-03"},"enrollment":45,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Familial Chylomicronemia Syndrome (FCS)"],"interventions":[{"type":"DRUG","name":"LCQ908","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":["LCQ908"]}],"arms":[{"label":"LCQ908 20 mg","type":"EXPERIMENTAL"},{"label":"LCQ908 40 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether LCQ908 is effective and safe in lowering triglycerides in subjects with Familial Chylomicronemia Syndrome (FCS) (Hyperlipoproteinemia \\[HLP\\] type I). Data from this study will be used to support a registration submission of LCQ908 20 mg and 40 mg as treatment of chylomicronemia in subjects with FCS (HLP Type 1).","primaryOutcome":{"measure":"Percent Change in Fasting Triglycerides From Baseline to 12 Weeks","timeFrame":"Baseline to 12 weeks","effectByArm":[{"arm":"Placebo","deltaMin":45.6,"sd":null},{"arm":"LCQ908 20mg","deltaMin":3.7,"sd":null},{"arm":"LCQ908 40 mg","deltaMin":-13.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0538"},{"comp":"OG000 vs OG002","p":"0.0182"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":14,"countries":["United States","Canada","France","Germany","Netherlands","South Africa","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":15},"commonTop":["DIARRHOEA","NAUSEA","VOMITING","ABDOMINAL PAIN","NASOPHARYNGITIS"]}}